NCT03702309
- Conditions
- Adnexal Diseases, BRCA1 Mutation, BRCA2 Mutation, +85 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Hamartoma. Study availability and eligibility vary by location and protocol.
NCT03702309
NCT00001403
NCT00001975
NCT00001465
NCT00001532
NCT06462430
NCT06888388
NCT07287202
NCT06081348
NCT07575347